once-MONTHLY bisphosphonate called Boniva (ibandronate)

April 2005

You'll hear about the new once-MONTHLY bisphosphonate called Boniva (ibandronate) this month. It's a 150 mg tablet.

A 2.5 mg Boniva was approved over a year ago, but never marketed. The company was waiting for approval on monthly dosing. Otherwise they'd have no significant advantage over weekly Actonel or Fosamax.

All the costs are roughly comparable.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote